Dengue virus infection with highly - neutralizing levels 1 of cross - reactive antibodies cause acute lethal small 2 intestinal pathology without high level of viremia in 3 mice . 4 5 6
نویسندگان
چکیده
mice. 4 5 6 Satoru Watanabe, Kitti Wing Ki Chan, Jiaqi Wang, Laura Rivino, Shee-Mei Lok and 7 Subhash G. Vasudevan* 8 9 Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 10 8-College Road, Singapore 169857 11 12 *Corresponding Author: Subhash G. Vasudevan 13 Program in Emerging Infectious Diseases, DUKE-NUS Graduate Medical School, 8 14 College Road, Singapore 169857, Phone: +65 6516 6718, Fax: +65 6221 2529 15 Email: [email protected] 16 17 Running Title: Antibody neutralized dengue virus mediated severe disease 18 19 Word count: abstract; 242 words, text; 6982 words 20 JVI Accepted Manuscript Posted Online 18 March 2015 J. Virol. doi:10.1128/JVI.00216-15 Copyright © 2015, American Society for Microbiology. All Rights Reserved.
منابع مشابه
Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
Immunity to one of the four dengue virus (DV) serotypes can increase disease severity in humans upon subsequent infection with another DV serotype. Serotype cross-reactive antibodies facilitate DV infection of myeloid cells in vitro by promoting virus entry via Fcgamma receptors (FcgammaR), a process known as antibody-dependent enhancement (ADE). However, despite decades of investigation, no in...
متن کاملRelationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.
BACKGROUND Infection with any 1 of the 4 dengue viruses (DVs) can produce several illnesses, ranging from a mild febrile illness to classic dengue fever (DF) to dengue hemorrhagic fever (DHF), a potentially life-threatening disease. Most DHF cases occur after sequential heterotypic DV infections. The role of preexisting humoral immunity in modifying severity of dengue disease is not well unders...
متن کاملNeutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein
Dengue virus (DENV) infection imposes enormous health and economic burden worldwide with no approved treatment. Several small molecules, including lovastatin, celgosivir, balapiravir and chloroquine have been tested for potential anti-dengue activity in clinical trials; none of these have demonstrated a protective effect. Recently, based on identification and characterization of cross-serotype ...
متن کاملMeasuring dengue enhancing antibodies: caveats.
To the Editor-Laoprasopwattana et al. [1] concluded that "levels of preillness plasma EA [enhancing activity] or DV [dengue virus] infection in K562 cells did not correlate with the clinical severity or viral burden of secondary DV infection" (p. 510). Sadly, serious flaws in their study's design and methodology preclude rigorous interpretation of these data. Nonetheless, the authors have ident...
متن کاملAcute Systemic Infection with Dengue Virus Leads to Vascular Leakage and Death through Tumor Necrosis Factor-α and Tie2/Angiopoietin Signaling in Mice Lacking Type I and II Interferon Receptors
Severe dengue is caused by host responses to viral infection, but the pathogenesis remains unknown. This is, in part, due to the lack of suitable animal models. Here, we report a non-mouse-adapted low-passage DENV-3 clinical isolate, DV3P12/08, derived from recently infected patients. DV3P12/08 caused a lethal systemic infection in type I and II IFN receptor KO mice (IFN-α/β/γR KO mice), which ...
متن کامل